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Abstract
The purpose of this thesis was to investigate the effects that exercise modalities have on
neurotrophic and inflammatory blood markers and cognitive outcomes in older adults. A
systematic review and meta-analysis were completed. The included studies illustrated that
most of the literature evaluated the effect of aerobic exercise interventions on systemic
concentrations of the blood marker brain-derived neurotrophic factor (BDNF). The
review found that aerobic exercise increases BDNF and resistance training increases
insulin-like growth factor 1 (IGF-1). Interventions with sex-specific cohorts presented
advantages in males for blood marker and cognitive outcomes compared to females. One
of three included interventions decreased C-reactive protein (CRP). This thesis
demonstrated the presence of modality-specific outcomes of exercise on blood markers
and presents a targeted review of the literature evaluating exercise, cognition, and blood
markers.
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Summary for Lay Audience
Dementia poses a huge burden to older adults, their caregivers, and society. Patients with
dementia are faced with increasingly severe and complex impairments to their thinking,
otherwise known as cognition, which includes processes such as memory, planning,
organization, attention, language, spatial ability, and ability to orient themselves.
Additionally, individuals with dementia typically face challenges with mobility, social
life, and mental health as their condition progresses.
A possible treatment for dementia is exercise, which has been shown to (at least
temporarily) improve or prevent worsening of the symptoms of cognitive decline in older
adults. Past research on exercise as a treatment for individuals with cognitive
impairments has suggested that exercise triggers a release of specific molecules in the
blood and, conversely, reduces harmful molecules. More specifically, exercise triggers
the release of molecules, known as growth factors, that increase blood flow and regulate
the development, growth, and survival of brain cells. Also, exercise decreases molecules
in the blood that are related to heart disease and dementia, known as inflammatory
markers.
This manuscript aimed to examine the role of key growth factors and inflammatory
markers in the cognitive outcomes seen after an exercise program. A review of this
subject was completed and organized to clarify the consensus of all past literature.
The review found that different exercise types (resistance and aerobic) increased different
growth factors in the blood. Males showed more positive effects on both blood molecules
and mental processes after exercise. Additionally, inflammatory markers were reduced
after exercise in some studies. In conclusion, this manuscript suggested that different
types of exercise can increase growth factor molecules to improve cognition, and that
exercise can protect against age-related declines in memory and growth factor levels in
the blood.
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Chapter 1

1

Literature Review

This thesis aims to evaluate the relationship between longitudinal exercise training and
cognition, and whether this relationship is modified by neurotrophic growth factors and
inflammation. Chapter 1 will introduce the topics of cognition, exercise, neurotrophic
factors, and inflammatory markers. Further, I present the topic of exercise as a nonpharmacological intervention to reduce age-related cognitive decline. Additionally, I
describe the impact of growth factors and inflammation on cognition and the role of
exercise in this relationship. I conclude by providing study rationale, purpose, and
hypotheses of the ensuing chapters. Chapter 2 presents a review of randomized controlled
trials investigating the impact of particular exercise modalities on neurotrophic factor and
inflammatory marker concentrations and cognition.

1.1

Cognition in Aging

Cognition is defined as the mental action or process of acquiring knowledge and
understanding through thought, experience, and the senses (Harada et al., 2013).
Cognitive decline is a natural result of aging (Harada et al., 2013; Murman, 2015). The
physiological processes that drive age-related cognitive decline are multifaceted,
interconnected, and largely undetermined (Harman, 2006; López-Otín et al., 2013;
Salthouse, 2010). Aging increases the risk of developing cognitive pathologies, which
can further compound the deleterious effects of cognitive aging (Riedel et al., 2016).
Researchers have delineated associations between several lifestyle factors and resilience
to cognitive aging and pathology. Specifically, education, social engagement, physical
fitness, and life occupation, among others, have been linked to better prognoses of
cognitive aging (Harada et al., 2013). Also, acute and longitudinal health interventions,
such as exercise (Northey et al., 2018), cognitive training, or playing a musical
instrument (Román-Caballero et al., 2018), have exhibited positive results as preventative
treatments for cognitive decline.
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An interesting clinical phenomenon, cognitive reserve, explains the disjunction between
the expression of cognitive symptoms and the disproportionate severity of cognitive
pathology present in post-mortem clinical findings (Ince, 2001; Stern, 2009). More
specifically, cognitive reserve is hypothesized to be an individual’s ability to cope with
injury to the brain or cognitive decline through the individual differences in neural
networks and the capacity to reallocate intact networks to surrogate the function of
damaged networks. Cognitive reserve is postulated to be primarily driven by education,
occupational exposure, leisure activities, and general cognitive activity throughout the
lifespan (Stern, 2009; Wilson et al., 2007).

1.1.1

Domains of Cognition

There is limited consensus in research and healthcare on the most effective way to divide
cognition into distinct neurocognitive domains. To attain consistent diagnostic
categorisation of cognitive impairments, the Diagnostic and Statistical Manual of Mental
Disorders, fifth edition (DSM-5), gained consensus from leading experts of psychiatric
research and practice. Based on the consensus established in the DSM-5, cognition is
divided into six principle domains: Executive Function, Complex Attention, Learning and
Memory, Perceptual Motor Functioning, Language, and Social Cognition (Sachdev et al.,
2014).
Hunt et al. (2013) defines executive function as an overarching cognitive process,
mediated by attention, that coordinates and integrates multiple subordinate cognitive
skills to enable goal-directed behaviour. Executive function is categorized into several
sub-domains, including planning, decision making, working memory, responding to
feedback, inhibition, and flexibility (Sachdev et al., 2014). Additionally, Miyake et al.
(2000) explored the existence of three frequently postulated executive sub-components:
inhibition, shifting, and updating. These three sub-components can respectively be
defined as the ability to suppress dominant, automatic, or prepotent responses when they
are inappropriate, as the ability to shift attention between different sub-tasks or different
elements of the same tasks, and finally, as the ability to evaluate incoming information
and revise the existing contents of working memory by deleting what is no longer
relevant and incorporating more recent salient information.
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Attention is defined as the behavioral and cognitive process of selectively concentrating
on a discrete aspect of information, whether deemed subjective or objective, while
ignoring other perceivable information (Anderson, 2004). Complex attention is
categorized into several sub-domains including sustained attention, divided attention,
selective attention, and processing speed. (Sachdev et al., 2014).
The Encyclopedia of Psychology defines learning as the acquisition of a skill or
knowledge, and memory as the expression of previously learned information (Kazdin et
al., 2000). Learning and memory are categorized into the sub-domains free recall, cued
recall, recognition memory, semantic and autobiographical, long-term memory, and
implicit memory (Sachdev et al., 2014).
Perceptual-motor function is the accurate integration of sensory information for the
development of motor programming and perceptual orientation (Finney, 2015). This
cognitive domain is categorized into visual perception, vasoconstriction reasoning, and
perceptual-motor coordination (Sachdev et al., 2014).
Language is defined as the development, acquisition, and maintenance, and use of
complex systems of communication (Ramlan, 2018). Language is differentiated into subdomains that include object naming, word finding, fluency, grammar and syntax, and
receptive language (Sachdev et al., 2014)

1.1.2

Epidemiology of Cognitive Dysfunction

The intermediate state between normal aging and dementia is known as mild
neurocognitive disorder (Sachdev et al., 2014), or more commonly mild cognitive
impairment (MCI). The prevalence of MCI is 10-20% in older adults over 65 years of age
(Langa & Levine, 2014). Those diagnosed with MCI have a 20-40% (10-15% per year)
risk of progression into dementia (Roberts & Knopman, 2013). The most significant risk
factors of cognitive decline and cognitive pathology are age, sex, genetics, and the
presence of diabetes or cardiovascular disease (Biessels & Despa, 2018; Riedel et al.,
2016).
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The prevalence of cognitive decline is predicted to rise substantially in the approaching
decades. Researchers predict that by 2050 the population of those 65 years and older will
double, while the population of those 85 years and older will triple. Further, it is
estimated that 35.6 million people live with dementia worldwide, and this number will
double every 20 years (Mavrodaris et al., 2013). Consequently, interest in research has
risen dramatically for the treatment or prevention or cognitive decline (Cummings et al.,
2018; Morrison-Bogorad et al., 2007).
Research suggests that females are more susceptible to cognitive pathologies compared to
males (Barha & Liu-Ambrose, 2018); the incidence of cognitive decline is twice as likely
in female older adults (Lin & Doraiswamy, 2015) and females exhibit more rapid brain
atrophy than males after onset of cognitive pathology (Hua et al., 2010). Also, the
association between peripheral inflammatory markers and cognitive decline is more
evident in females than males (Trollor et al., 2012). Further, both natural and surgical
menopause are associated with an increased risk of Alzheimer’s disease biomarkers and
cognitive decline (Hara et al., 2015; Mosconi et al., 2017; Rocca et al., 2007; Scheyer et
al., 2018).

1.1.3

Measuring Cognitive Function

Various cognitive assessments have been validated in measuring cognitive performance
in different age groups. These assessments can be combined to measure cognitive
performance in general, or particular domains of interest. Cognitive assessments
commonly used for older adults include: Trail Making Test (Reitan and Wolfson 1985),
Digit Span (Wechsler, 1981), Letter Number Sequence (Wechsler, 1981), and Language
or Category Fluency (Strauss et al., 2006), and Rey Auditory Verbal Learning Test
(Rosenberg et al., 1984). Various cognitive assessment batteries that include multiple
assessments have been developed for comprehensive assessments of older adults. Most
notable are the Montreal Cognitive Assessment (MoCA), the Mini Mental State
Examination (MMSE), both of which are short assessments typically used as screening
tools (Tavares-Júnior et al., 2019; Woodford & George, 2007); and the Alzheimer
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Disease Assessment Scale (ADAS-Cog) that has been used in clinical trials (Kueper et
al., 2018; Montero Odasso et al., 2018; Rosen et al., 1984).
The ADAS-Cog is a valid and reliable battery of cognitive assessments to determine
global cognition related to cognitive impairment in older adults (Sheehan, 2012). The
ADAS-Cog Plus, a revised version of the ADAS-Cog, incorporates additional measures
of executive function and functionality. This scale consists of 10 cognitive tests, with
scores ranging from 0 to 90; higher scores represent poorer cognitive performance
(Skinner et al., 2012). Compared to previous versions, the ADAS-Cog Plus is more
responsive to disease progression and treatment effects in studies of cohorts with MCI
(Kueper et al., 2018). The ADAS-Cog has been a significant outcome measure in
numerous trials with MCI and AD (Chupel et al., 2017; Fiatarone Singh et al., 2014;
Öhman et al., 2014; Suzuki et al., 2013; Toots et al., 2017).

1.2

Physical Exercise

Caspersen, Powell, and Christenson (1985) define exercise as “Physical activity that is
planned, structured, repetitive, and purposive in the sense that improvement or
maintenance of one or more components of physical fitness is an objective”. The
objective of physical exercise is physical fitness, which can be divided into two
components, with specific sub-categories: (1) health-related objectives, including
cardiorespiratory capacity, muscular endurance, muscular strength, body composition,
and flexibility; and (2) skill-related, including agility, balance, coordination, speed,
power, and reaction time. If a physical activity does not intentionally fulfil any of these
aspects of physical fitness, then it is not considered exercise.
In trials with older adults, the primary consideration of an exercise interventions is
usually health-related outcomes of strength, fall reduction, mobility, cardiovascular
fitness, physical function, depression, and cognitive outcomes (Cadore et al., 2013; Chen
et al., 2020; Shekelle et al., 2003). Common exercise modalities for older adults include
aerobic, resistance, stretching, and balance.
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1.2.1

Aerobic Exercise

Aerobic exercise involves the use of large muscle groups in dynamic activities that result
in sustained increases in heart rate and energy expenditure (Howley, 2001). Aerobic
exercise is primarily related to the health-related outcomes of cardiorespiratory capacity,
muscle endurance, and body composition due to the moderate-energy, long-duration
nature of the exercise (Plowman & Smith, 2008). Aerobic exercise is commonly
implemented on ergometer machines (treadmills, stationary bikes, ellipticals, rowing
machines, etc.), walking, running, or biking, depending on the fitness level and capability
of the subjects.

1.2.2

Resistance Exercise

Resistance exercise is the repeated lifting of weight to overload muscles at an intensity
only sustainable for a short duration. The parameters of resistance training include the
number of times the resistance is moved in a single set of exercise, the number of sets
done, and the rest interval between sets (Howley, 2001). Resistance exercise is primarily
related to the health-related outcomes of muscular strength, muscular endurance, and
body composition. Also, secondary skill-related enhancements in balance, agility, speed,
and power can be attained through resistance exercise (Plowman & Smith, 2008).
Common forms of resistance training include the use of free-weights, resistance machines
(e.g., leg press, chest press, leg curl, etc.), resistance bands, and body weight exercises
(e.g., pull-ups, push-ups, bodyweight squats, etc.).

1.2.3

Balance, Toning, and Stretching Exercise

Balance, toning, and stretching exercises usually exercises that are designed to improve
balance, muscle tone, and lengthen muscles, respectively. Balance exercises typically
challenge balance systems by limiting senses related to balance, such as sight,
proprioception, foot pressure, and vestibular function, and limiting the base of support
with or without perturbing the centre of gravity of the participant. Common balance
exercises include one-leg stance, standing with eyes closed, standing on a foam pad, or
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tandem stance, all usually administered over a set duration (Penzer et al., 2015; Shimada
et al., 2003). Toning exercises are exercises that utilize large muscle groups but do not
significantly overload the muscles or cause a significant cardiovascular response. Finally,
stretching exercises are movements intended to lengthen muscles and improve range of
motion for targeted joints (Page, 2012).
Balance, toning, and stretching exercises are commonly used in-combination as active
controls for exercise interventions in cognitive trials. This is due to a speculated lack of
amelioration on cognitive dysfunction (Kelly et al., 2014; Uffelen et al., 2008). However,
some forms of this modality are studied due to their proposed mental and emotional
enhancements, such as yoga, tai chi, and Qigong (Abbott & Lavretsky, 2013; Farhang et
al., 2019; Mooventhan & Nivethitha, 2017).

1.3

Blood Biomarkers Related to Cognition

Particular blood biomarkers have been identified as having important roles in the
regulation of cognitive functioning. Specifically, neurotrophic growth factors (Campos,
Rocha, Lattari, Paes, & Nardi 2016; Raab et al., 2004), and inflammatory cytokines (Gu
et al., 2017; Teunissen et al., 2003) have been found to exert trophic and atrophic effects
on the neural and vascular structures in the brain, respectively (Cotman et al., 2007;
Nascimento et al., 2014).

1.3.1

Neurotrophic Factors

Studies have identified particular neurotrophic factors thought to be associated with
positive cognitive outcomes after exercise (Ding et al., 2006; Hillman et al., 2008). The
primary neurotrophic growth factors implicated in this relationship are brain-derived
neurotrophic factor (BDNF), insulin-like growth factor 1 (IGF-1), and vascular
endothelial growth factor (VEGF) (Cotman et al., 2007). These molecules play
convergent roles in the neuroplastic processes, including gliogenesis, neurogenesis,
synaptogenesis, and angiogenesis (El-Sayes et al., 2019).
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The protein BDNF is expressed in the central nervous system, gut, and other tissues, and
is a member of the neurotrophin family (Bathina & Das, 2015). Functionally, BDNF
enhances the growth and differentiation of cells in the brain and is essential to the
development of the mammalian brain (Binder & Scharfman, 2004). Specifically, the
expression of BDNF contributes to neurogenesis (Benraiss et al., 2001; Pencea et al.,
2001), gliogenesis (Cheng et al., 2006), synaptogenesis (Aguado et al., 2003; Alsina et
al., 2001; Binder & Scharfman, 2004) and angiogenesis (Kermani & Hempstead, 2007).
BDNF is largely expressed in the hippocampus, which is the brain centre for emotion,
memory, and learning (Erickson et al., 2011; Lu et al., 2014). Low blood concentrations
of BDNF have been associated with neurodegenerative diseases, such as dementia
(Weinstein et al., 2014), Alzheimer’s disease (Laske et al., 2006; Ng et al., 2019),
Huntington’s disease (Zuccato & Cattaneo, 2009), and the early stages of Parkinson’s
disease (Huang et al., 2018).
The signal protein VEGF is released from the endothelial cells in blood vessels,
macrophages, and glial cells in response to tissue hypoxia (Roskoski, 2007; Tang et al.,
2010) and the presence of blood lactate (Morland et al., 2017) and functions to stimulate
angiogenesis and vasculogenesis ubiquitously in the body (Hoeben et al., 2004). VEGF
transcription in the brain is thought to elicit neurotropic and neuroprotective functions
(Jin et al., 2002; Sun et al., 2003; Tang et al., 2010). The specific functions of VEGF are
increasing neuronal survival, decreasing apoptotic proteins and signals, stimulating the
release of proteins that improve neuronal health (Sanchez et al., 2010), and increasing
general plasticity of mature neurons (Licht et al., 2011). Animal studies have discovered
a marked decline in VEGF concentrations in the hippocampus occurring until middle-age
that may contribute to age-related cognitive decline (Shetty et al., 2005).
The vascular and neuroprotective functions of VEGF are especially pertinent in the
context of vascular dementia (Ding et al., 2004; Sun et al., 2003). After a cerebral
vascular event, such as a stroke, VEGF is released to the affected area to promote
angiogenic and vasculogenic activity (Krupinski et al., 1994). Patients who have
experienced a cerebral vascular event (i.e. stroke) with higher systemic concentrations of
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VEGF have significantly better prognoses than those with lower systemic concentrations
(Lee et al., 2010). Interestingly, patients afflicted by an acute stroke who had previous
transient ischemic attacks (TIA) have better prognoses than those without, thought to be
mediated by a higher concentration of VEGF following the damage associated with TIA
(Kwon et al., 2015). Thus, the negative impacts of stroke may be mitigated by high
concentrations of VEGF in the cerebral vasculature due to its role in angiogenesis and
vasculogenesis.
The protein hormone IGF-1 is released by cells of the liver, lungs, kidneys, skeletal
muscle, heart, and white adipose tissue in the presence of circulating growth hormone

(GH) (Lowe et al., 1988). The primary function of IGF-1 is to stimulate anabolism
throughout the mammalian body (Le Roith et al., 2001), including neurogenesis (LlorensMartín et al., 2009), gliogenesis (Carson et al., 1993), synaptogenesis (Trejo et al., 2007),
and angiogenesis (Lopez-Lopez et al., 2004) and is essential for human brain
development (Maggio et al., 2012). As humans age, systemic concentrations of GH
typically decrease, resulting in a downregulation of IGF-1 (Corpas et al., 1993). Further,
research has shown that lower concentrations of IGF-1 are associated with cognitive
aging (Corpas et al., 1993; Sonntag et al., 2005); lower cognitive functioning in older
adults, with, and without, MCI; and an increased risk of Alzheimer’s disease and vascular
dementia (Watanabe et al., 2005) .

1.3.2

Inflammation and Inflammatory Cytokines

Inflammation is the body’s immune response to harmful stimuli and functions to
eliminate necrotic cells and promote healing. Although inflammation is beneficial and
necessary for normal bodily functioning (Gronke et al., 2019), chronic low-grade
inflammation is particularly detrimental to heart and brain health (Nicklas & Brinkley,
2009). The incidence of inflammatory pathogenesis is dependent on the level of
inflammation in an individual’s body and their threshold of disease, adjusted by genetic
and environmental influences (Franceschi et al., 2006).
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The term inflammaging refers to a chronic low-grade inflammatory state resulting from
the upregulation of the inflammatory response compelled by multiple factors in old age.
These factors are speculated to be driven by the culmination of antigenic stressors over
the human lifespan and dysregulated inflammatory processes (Rea et al., 2018).
Inflammaging likely represents a mechanism underlying the age-related functional
decline across a variety of pathological states (Nicklas & Brinkley, 2009). Research has
also demonstrated an association between chronic low-grade inflammation and attenuated
hippocampal neurogenesis (Chesnokova et al., 2016; Kohman & Rhodes, 2013),
increased risk of stroke with poor functional outcomes and mortality (Ballantyne et al.,
2005; Elkind et al., 2006), cognitive impairment (Wichmann et al., 2014), and
Alzheimer’s disease (Heneka et al., 2015; Krabbe et al., 2004). Multiple studies
measuring the effect of inflammation on cognition have employed the inflammatory
cytokines interleukin 6 (IL-6) and C-reactive protein (CRP) as valid markers of systemic
inflammation and inflammaging (Capuron et al., 2011; Gabay & Kushner, 1999; Ohzato
et al., 1992; Tegeler et al., 2016; Yaffe et al., 2003).
The inflammatory protein IL-6 is secreted by macrophages and T-cells in the bloodstream
and has both pro- and anti-inflammatory functions (Pedersen & Febbraio, 2008; Scheller
et al., 2011). Specifically, IL-6 is released as a pro-inflammatory cytokine in response to
injury, cell damage, and cell death. However, in response to muscle contraction, IL-6 is
transiently released as an anti-inflammatory myokine (Pedersen & Febbraio, 2008).
Though IL-6 has anti-inflammatory pathways, elevated concentrations of IL-6 in the
systemic circulation have been associated with lower cognitive performance (Bradburn et
al., 2018; Trollor et al., 2012) and brain volume (Gu et al., 2017). This relationship is
thought to be mediated through the detrimental effects of chronic low-grade
inflammation as well as inflated cytokine responses to ischemia that exacerbate cell
damage in the brain (Michaud et al., 2013).
The protein CRP is an acute-phase inflammatory protein that is released from the liver in
response to circulating IL-6 (Pepys & Hirschfield, 2003). The measurement of CRP is
used as a standard clinical procedure that indicates the systemic level of inflammation in
an individual, usually administered on older adults at-risk for cardiovascular events,
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infections, or inflammatory disorders (Bray et al., 2016; Pepys & Hirschfield, 2003).
High concentrations of CRP are associated with cognitive decline, dementia, and an
increased risk of stroke (Kuo et al., 2005; Misiak et al., 2018).

1.4

Exercise as a Treatment for Cognitive Decline in
Aging

The use of exercise as a non-pharmaceutical intervention to delay or prevent the
trajectory into dementia is a rapidly growing field of interest. Longitudinal exercise
programs have shown promise in eliciting significant improvements in cognitive
performance with modality-dependent domain-specific effects (Barha, Davis, Falck,
Nagamatsu, & Liu-Ambrose, 2017). A meta-analysis, which included individuals over 50
years of age, found that exercise elicited a positive small to moderate effect on improving
cognitive performance. This effect was consistent regardless of cognitive status, cognitive
domains measured, and the exercise modality utilized (Northey et al., 2018). Other metaanalyses have investigated this relationship in participants with MCI with variable results.
In particular, studies primarily found small to moderate improvements in global
cognition, memory, and executive function (Biazus-Sehn et al., 2020; Zheng et al., 2016).
Conversely, Gates, Singh, Sachdev, & Valenzuela (2013) completed a meta-analysis on
the effect of exercise on cognition in individuals with MCI, but did not find significant
outcomes. Interestingly, Biazus-Sehn et al. (2020) found that trials utilizing more
cognitively engaging forms of exercise (i.e., dance, Tai Chi, Baduanjin) in older adults
with MCI had better cognitive outcomes than simple physical exercise regimens. These
findings are consistent with the results from a meta-analysis investigating the effect of
aerobic dance interventions on cognition. The study found that the dance interventions
had a moderate effect on memory, executive function, and global cognition (Zhu et al.,
2020). These results may be indicative of a synergistic training effect related to the
cognitive as well as physiological demands of exercise.
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1.4.1

Physical Exercise and Blood Markers Associated
with Cognition

Exercise-induced physiological cascades are known to regulate cognition by exerting
trophic effects on neural and vascular structures in the brain (Campos, Rocha, Lattari,
Paes, & Nardi 2016; Raab et al., 2004) and preventing brain atrophy associated with
inflammation (Gu et al., 2017; Teunissen et al., 2003). Consequently, the relationship
between physical exercise and cognition is thought to be mediated by the change in
growth factors and inflammatory markers (Cotman et al., 2007; Nascimento et al., 2014)

1.4.1.1 Neurotrophic Growth Factors and Cognition in
Response to Exercise
Neurotrophic growth factors mediate the effects of exercise on cognitive performance.
Comprehensive reviews have established that BDNF, VEGF, and IGF-1 are the principal
mediating neurotrophic growth factors in the exercise-cognition relationship (Cotman et
al., 2007; El-Sayes et al., 2019). Figure 1.1 describes the model of neurotrophic growth
factor and cognitive outcomes induced by physical exercise. Animal trials have
established divergent exercise modality-dependent relationships for neurotrophic growth
factors and cognitive outcomes. In particular, it is thought that aerobic exercise increases
BDNF concentrations and resistance training upregulates IGF-1 activity, both mediating
improvements of cognitive outcomes (Cassilhas et al., 2012). A meta-analysis by Dinoff
et al. (2016) investigating the effect of exercise on concentrations of BDNF supported
this theory that aerobic and not resistance exercise increased resting systemic BDNF
concentrations in humans. Other RCTs have supported these speculated modality-specific
pathways to improve cognitive outcomes (Cassilhas et al., 2007; Jiang et al., 2020; Tsai
et al., 2019), as well as possible synergistic effects of multimodal exercise interventions
(Annibalini et al., 2017). The effect of exercise on VEGF in cognitive trials in humans
has been studied considerably less than BDNF and IGF-1. In fact, most of the literature
on this relationship has been established through animal trials (Cao et al., 2004; Y.-H.
Ding et al., 2004; Fabel et al., 2003; Lopez-Lopez et al., 2004; Prior et al., 2004) and
results in human trials are variable. A recent systematic review on exercises effects on
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VEGF in older adults describes that four of ten studies found significant increases in
VEGF concentrations post-intervention. The review was limited by the small number of
included studies, and a wide variety of intervention parameters (exercise duration,
frequency, intensity, type) and sample characteristics (Vital et al., 2014). Further research
evaluating the effect of exercise on VEGF to affect cognition is required to delineate this
relationship in humans.

Longitudinal Exercise

↑ BDNF

Gliogenesis

↑VEGF

↑ IGF-1

Neurogenesis

Synaptogenesis

Angiogenesis

Structural and Functional
Brain Changes

↑ Cognitive Functioning

Figure 1.1 Model of neurotrophic growth factor response and action after longitudinal
exercise
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1.4.2.2 Inflammation and Cognition in Response to Exercise
Longitudinal exercise attenuates inflammation and improves cognition (Gleeson et al.,
2011). Figure 1.2 describes the possible mechanisms in which inflammatory cytokines
mediate cognitive changes after longitudinal exercise. The mechanism driving the antiinflammatory response of exercise is largely unknown, but the overall relationship has
been well established. Specifically, recent meta-analyses found that exercise was
associated with significant decreases in IL-6 concentrations in older adults with cognitive
impairments (Stigger et al., 2019) and resistance training was associated with decreases
in CRP and IL-6 concentrations for older adults (Sardeli et al., 2018). Further, multiple
randomized controlled trials (RCTs) have found evidence that longitudinal exercise
reduces inflammation. In particular, concentrations of CRP and IL-6 were reduced by
dance training (Borges et al., 2019), combined aerobic and resistance training (Annibalini
et al., 2017; Balducci et al., 2010), and high-intensity aerobic training, but not lowintensity aerobic training (Balducci et al., 2010). Other trials found that aerobic and
resistance training interventions both decreased CRP, but not IL-6 concentrations
(Donges et al., 2010) and did not influence CRP or IL-6 concentrations (Libardi et al.,
2012). Cognition, however, was not measured in the aforementioned reviews or RCTs.
Exercise interventions that included the measurement of both cognition and inflammation
found unanimously that CRP decreased while cognitive performance improved. These
RCTs utilized resistance training (Chupel et al., 2017) and aerobic training (Alghadir et
al., 2016).
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Longitudinal Exercise

↓CRP

↓Neuroinflammation

↓Risk/Severity of Stroke

↓IL-6

↑Neurogenesis

Structural and Functional
Brain Changes

↑ Cognitive Functioning

Figure 1.2 Model of inflammatory cytokine response and outcomes after longitudinal
exercise.
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1.5

Overview of Thesis

1.5.1

Study Rationale

The previous sections summarize the literature surrounding cognition and exercise and
explores the how neurotrophic growth factors and inflammation interact with this
relationship. Evidence suggests that exercise may have advantages in ameliorating
cognitive impairment. However, the varying effects of exercise modalities and
subsequent biomarkers involved in this relationship have not been sufficiently explored
in research. Exercise modalities may drive divergent changes at the molecular level (i.e.,
neurotrophic and inflammatory markers), which may describe the changes at the
cognitive level in older adults.

1.5.2

Purpose

The purpose of this thesis was to systematically review the effects of exercise modalities
on neurotrophic factors, inflammation, and cognition, among older adults and to perform
a meta-analysis of the included studies, if feasible.

1.5.3

Hypotheses

It was hypothesized that:
1) The increase in neurotrophic factor and decrease in inflammatory marker
concentrations, as a result of exercise, will be associated with cognitive outcomes.
1.1) Exercise will increase growth factor concentrations, which will be associated with an
improvement in cognition.
1.2) Exercise will decrease inflammatory markers, which will be associated with an
improvement in cognition.
2) Higher baseline concentrations of growth factors and lower baseline concentrations of
inflammatory markers will be associated with improvements in cognitive outcomes.
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Physical exercise has been shown to prevent age-related cognitive decline, and has even
led to significant cognition improvement in older adults (Ahlskog et al., 2011; Bherer and
Erickson, 2013; Groot et al., 2016; Hess et al., 2014; Öhman et al., 2014). The underlying
mechanisms for these improvements are unknown but emerging evidence shows that
physical exercise increases neurotrophic factors (which consist of a family of molecules
that support the growth and survival of neurons). Conversely, concentrations of
inflammatory cytokines (which impair signal transduction of neurons) are significantly
decreased following physical exercise, suggesting that exercise may have a mechanistic
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role in promoting cognitive improvement (Cotman et al., 2007). It is hypothesised that
these changes stimulate a physiological cascade that promotes angiogenesis, gliogenesis,
neurogenesis, and synaptogenesis, while reducing systemic inflammation (Cotman et al.,
2007; El-Sayes et al., 2019; Nicklas and Brinkley, 2009).
Several studies have identified neurotrophic and inflammatory markers associated with
positive cognitive outcomes after exercise (Ding et al., 2006; Hillman et al., 2008). The
primary neurotrophic factors implicated in this relationship are brain-derived
neurotrophic factor (BDNF), insulin-like growth factor 1 (IGF-1), and vascular
endothelial growth factor (VEGF) (Ahlskog et al., 2011; Cotman et al., 2007; Voss et al.,
2013). Alternatively, inflammatory cytokines interleukin 6 (IL-6) and C-reactive protein
(CRP) are valid markers of systemic inflammation that impede neuronal signalling
(Capuron et al., 2011; Gabay and Kushner, 1999; Ohzato et al., 1992; Tegeler et al.,
2016; Yaffe et al., 2003).
Mechanistically, the aforementioned inflammatory cytokines and neurotrophic factors
influence cognitive performance via a cascade of neurological processes. For example,
BDNF regulates synaptic transmission in neural regions that are integrally related to
memory such as the hippocampus (Lu et al., 2014). Across a range of neural networks,
BDNF is also critically related to neuroprotection, neuromodulation, and neurogenesis
(i.e., gliogenesis and synaptic plasticity; Kowiański et al., 2018). Increases in
inflammatory cytokines, on the other hand, are associated with cognitive decline via
neuroinflammatory processes. CRP, for example, is strongly associated with the
progression of cognitive decline and the pathogenesis of the onset of dementia (Roberts
et al., 2009). Thus, efforts to enhance neurotrophic factors and reduce inflammatory
cytokines are essential in potentially increasing cognitive performance in individuals at
risk for developing dementia.
A recent systematic review and meta-analysis investigated the changes in neurotrophic,
inflammatory, and oxidative biomarkers after exercise interventions in older adults with
mild cognitive impairment and dementia (Stigger et al., 2019). The reviewers concluded
that physical exercise, specifically aerobic exercise, has a positive effect on BDNF
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expression, and a decrease in systemic concentrations of IL-6. However, this review was
limited by the lack of studies with cognitive performance measures, the limited number
of trials that met the inclusion criteria (n = 8), and the exclusion of cognitively healthy
participants.
To our knowledge, no prior systematic review has examined the distinct effects of the
main physical exercise modalities (aerobic, resistance, and multimodal) on serum
biomarkers in cognitive trials that included both cognitively healthy and cognitively
impaired older adults. The inclusion of studies targeting cognitive healthy and impaired
older adults may improve our understanding of how cognitive status affects blood marker
concentrations as well as cognitive outcomes after physical exercise. Further, this review
will summarize our existing knowledge of the physiological mechanisms driving the
neurotrophic, inflammatory, and cognitive outcomes after exercise. Therefore, the
purpose of this systematic review and meta-analysis was to investigate the effects of
physical exercise modalities on inflammatory and neurotrophic biomarker concentrations
in clinical trials that examined the effects of exercise on cognition in older adults.

2.1

Methods

2.1.1

Study Design & Search Strategy

This systematic review and meta-analysis was registered with PROSPERO –
CRD42019110522 (Appendix 1), an international database for prospectively registered
systematic reviews that are examining health-related outcomes.
We utilized the preferred reporting items for systematic reviews and meta-analyses
(PRISMA) statement (Moher et al., 2009). A literature search, without date or language
restrictions, was conducted via PubMed, SCOPUS, and EMBASE for literature published
prior to January of 2019. The search applied appropriate medical subject headings
(MeSH) in PubMed and SCOPUS, and subject headings in EMBASE (Tables 2.1, 2.2 ).
This systematic review was registered with PROSPERO – CRD42019110522 (Appendix
2), an international database for prospectively registered systematic reviews that are
examining health-related outcomes. We utilized the preferred reporting items for
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systematic reviews and meta-analyses (PRISMA) statement (Moher et al., 2009). A
literature search, without date or language restrictions, was conducted via PubMed,
SCOPUS, and EMBASE for literature published prior to January of 2019. The search
applied appropriate medical subject headings (MeSH) in PubMed and SCOPUS, and
subject headings in EMBASE (Tables 2.1, 2.2).

Table 2.1 Search terms.
Main Concepts

PubMed MeSH Term

EMBASE Subject
Heading

SCOPUS MeSH Term

Exercise

Exercise OR Physical
Exercise OR Physical
Activity

Exercise OR Physical
Activity OR Physical
Exercise

Exercise OR Physical
Activity OR Activities

Cognition

Cognition OR Cognitive
Dysfunction OR Cognitive
Impairment OR Executive
Function

Cognition OR Cognitive
Dysfunction OR Mild
Cognitive Impairment OR
Executive Function

Cognition OR Executive
Function

Elderly

Aged OR Elderly

Aged OR Elderly

Aged OR Elderly

Blood Biomarkers

Blood Biomarkers

Blood Biomarkers

Blood Biomarkers

Brain Derived
Neurotrophic Factor

Brian Derived Neurotrophic
Factor OR BDNF

Brian Derived
Neurotrophic Factor OR
BDNF

Brain-derived
Neurotrophic Factor OR
BDNF

Insulin-like Growth
Factor 1

Insulin-like Growth Factor 1
OR IGF-1

Insulin-like Growth Factor
1 OR IGF-1

Vascular Endothelial
Growth Factor

Vascular Endothelial
Growth Factor OR VEGF

Vascular Endothelial
Growth Factor OR VEGF

Vascular Endothelial
Growth Factor OR VEGF

Interleukin 6

Interleukin 6 OR IL-6

Interleukin 6 OR IL-6

Interleukin-6 OR IL-6

C-Reactive Protein

C-Reactive Protein OR CRP

C-Reactive Protein OR
CRP

C-Reactive Protein OR
CRP

Insulin-like Growth
Factor-1 OR IGF-1

Note: BDNF = Brian Derived Neurotrophic Factor; IGF-1 = insulin-like growth factor 1; VEGF =
vascular endothelial growth factor; IL-6 = interleukin 6; CRP = C-reactive protein.
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Table 2.2 Search strategy for PubMed, EMBASE, and SCOPUS.
Using PubMed Database
1. Exercise/ OR Physical Exercise/ OR Physical Activity/
2. Cognition/ OR Cognitive Dysfunction/ OR Cognitive Impairment/ Or Executive Function/
3. Aged/ OR Elderly/
4. Blood Biomarkers/
5. Brian Derived Neurotrophic Factor/ OR BDNF/
6. Insulin-like Growth Factor 1/ OR IGF-1/
7. Vascular Endothelial Growth Factor/ OR VEGF/
8. Interleukin 6/ OR IL-6/
9. C-Reactive Protein/ OR CRP/
10. Strategy 4 AND 5 OR 6 OR 7 OR 8 OR 9
11. Strategy 1 AND 2 AND 3 AND 10
Using EMBASE Database
1. Exercise/
2. Physical Activity/
3. Physical Exercise/
4. Strategy 1 OR 2 OR 3
5. Cognition/
6. Executive Function/
7. Mild Cognitive Impairment/
8. Strategy 5 OR 6 OR 7
9. Aged/
10. Elderly/
11. Strategy 10 OR 11
12. Blood Biomarkers/
13. Brian Derived Neurotrophic Factor/
14. BDNF/
15. Strategy 14 OR 15
16. Insulin-like Growth Factor 1/
17. IGF-1/
18. Strategy 17 OR 18
19. Vascular Endothelial Growth Factor/
20. VEGF/
21. Strategy 20 OR 21
22. Interleukin 6/
23. IL-6/
24. Strategy 23 OR 24
25. C-Reactive Protein/
26. CRP/
27. Strategy 26 OR 27
28. Strategy 4 AND 9 AND 12 AND 13 AND 16 AND 19 AND 22 AND 25 AND 28
Using SCOPUS Database
1. Exercise/
2. Physical Activity/
3. Activities/
4. Strategy 1 AND 2 AND 3
5. Cognition/
6. Cognitive Dysfunction/
7. Cognitive Impairment/
8. Executive Function/
9. Strategy 5 OR 6 OR 7 OR 8
10. Aged/
11. Elderly/
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12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.

2.1.2

Strategy 10 OR 11
Blood Biomarkers/
Brian Derived Neurotrophic Factor/
BDNF/
Strategy 14 OR 15
Insulin-like Growth Factor 1/
IGF-1/
Strategy 17 OR 18
Vascular Endothelial Growth Factor/
VEGF/
Strategy 20 OR 21
Interleukin 6/
IL-6/
Strategy 23 OR 24
C-Reactive Protein/
CRP/
Strategy 26 OR 27
Strategy 4 AND 9 AND 12 AND 13 AND 16 AND 19 AND 22 AND 25 AND 28

Screening

After completing the initial search, all duplicates were removed. To be included, articles
must have met the following criteria: 1) Published as a randomized controlled trial (RCT)
or quasi-randomized controlled trials (QRCT); 2) measured at least one of BDNF, VEGF,
IGF-1, CRP, and IL-6, both before and after a longitudinal (>1 session) exercise
intervention; 3) measured cognitive performance both before and after a longitudinal (>1
session) exercise intervention; 4) included a sample with a mean age of 60+ years, who
were not taking cognitive enhancers, neuroleptics, or anticholinergics, and with an
absence of neurological conditions with a residual motor deficit (Parkinson’s disease,
major stroke, multiple sclerosis), or depression, schizophrenia, severe anxiety, and drug
abuse.
The titles and abstracts of the remaining articles were independently screened by two
authors (JT and NB). The remaining articles then underwent a full-text review.
Disagreements of the selected articles based on the criteria were settled by consensus of
the two members, and if consensus could not be reached, the third reviewer (MMO) was
consulted to make a decision. The bibliographies of all included articles were handsearched for other potential articles that were missed during the initial search.

39
Caspersen et al. (1985) defined exercise as “Physical activity that is planned, structured,
repetitive, and purposive in the sense that improvement or maintenance of one or more
components of physical fitness is an objective”. Physical fitness is composed of two
categories inclusive of specific sub-categories: 1) Health-related: Cardiorespiratory
capacity, muscular endurance, muscular strength, body composition and flexibility; 2)
Skill-related: Agility, balance, coordination, speed, power, and reaction time.

2.1.3

Bias Assessment

The Cochrane Collaboration Tool (CCT) was used to appraise the risk of bias (Higgins et
al., 2011) because of its recommendation for use in systematic reviews examining RCTs
(Zeng et al., 2015). Additionally, the CCT has been used in other similar systematic
reviews examining exercise, cognition (Hess et al., 2014), and blood biomarkers (Stigger
et al., 2019). The CCT is a bias detection tool based on 7 domains, each of which can be
ranked as low, high, unclear or not applicable (Fig. 2). Reviewers agreed to be
conservative when deciding between two bias ratings by tending toward higher ratings of
bias.

2.1.4

Outcome Measures

The primary outcome measure was the change in concentrations of the specified blood
biomarkers (BDNF, VEGF, IGF-1, IL-6, CRP) from pre- to post-exercise intervention.
The secondary outcome was the change in cognitive performance scores on
neuropsychological assessments. Cognitive performance was split into five domains,
when available, as defined by the Diagnostic and Statistical Manual of Mental Disorders,
5th edition (DSM-5), criteria (Sachdev et al., 2014) The domains included: Learning and
memory (LM), Complex Attention (CA), Executive Function (EF), Language,
Perceptual-Motor Function (P-MF), and Global Cognition (GC).

2.1.5

Data Extraction

The following information was extracted from the articles selected for final analysis:
authors and publication date, country of origin, study design, sample characteristics
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(cohort, sample size, age), intervention details (exercise type, duration/frequency/time),
primary outcome (significant change in specified blood biomarker concentrations), and
secondary outcomes (cognitive changes in particular domains or global cognition, as
applicable) (Table 2.3, Table 2.4, Table 2.5).
Due to the lack of raw data (pre- and post-intervention means, or mean change values) in
almost half of the included trials (47 %), measures for the change in both blood
biomarker concentrations and cognitive performance outcomes were simplified to either a
“↑” representing a statistically significant increase and improvement, respectively, or a
“↓” representing a statistically significant decrease and decline, respectively. For the data
to be determined as statistically significant, results must be significant relative to both
within-group time analyses and between-group comparisons to the control group.
In addition to the qualitative analyses, we planned on examining the strength of the
evidence quantitatively by conducting a meta-analysis using Review Manager 5.3©.
Additional inclusion criteria for the MA were reporting mean and standard deviation
values at follow-up post-intervention in both control and experimental conditions.
Included studies were also required to report a sample size.
We set the minimum number of independent studies needed for our meta-analysis at
three. The data extracted were continuous and the meta-analysis was conducted using a
random effects model, producing standardized mean differences. The studies yielded
from our search varied considerably with respect to the populations sampled, with some
studies recruiting exclusively male participants (Kohanpour and Peeri, 2017) or
exclusively female participants (Damirchi et al., 2018), for example. A random-effects
model accounts for data that may include studies sampled from varying populations, for
which any potential effects of the intervention may differ. To account for these
differences in sampling and the assumption that all studies are not functionally
equivalent, we used a random-effects model. To assess heterogeneity (the extent to which
differences underlying each study’s results are genuine), I2 values were used.
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Random sequence generation (selection bias)
Allocation concealment (selection bias)
Blinding of participants and personnel (performance bias)
Blinding of outcome assessment (detection bias)
Incomplete outcome data (attrition bias) - Post-Intervention
Selective reporting (reporting bias)
Other bias
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

Figure 2.1 Risk of bias graph. Green = low risk; red = high risk; yellow = unclear;
and grey = not applicable (NA).

Allocation concealment (selection bias)

Blinding of participants and personnel (performance bias)

Blinding of outcome assessment (detection bias)

Incomplete outcome data (attrition bias) - Post-Intervention

Selective reporting (reporting bias)

Other bias

Alghadir et al., 2016
Baker et al., 2010a
Baker et al., 2010b
Cassilhas et al., 2007
Chupel et al., 2017
Damirchi et al., 2018
Erickson et al., 2011
Fragala et al., 2014
Kohanpour et al., 2017
Leckie et al., 2014
Maass et al., 2016
Muscari et al., 2009
Rehfeld et al., 2018
Ruiz et al., 2015
Tarazona-Santabalbina et al., 2016
Tsai et al., 2015
Vaughan et al., 2014

Random sequence generation (selection bias)
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Figure 2.22Risk of bias summary. Green (+) = low risk; red (-) = high risk; yellow (?)
= unclear; and grey = not applicable (NA).
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2.2

Results

2.2.1

Search Results and Bias Assessment

Figure 2.1 summarizes all steps in the study selection process. A total of 942 articles
were identified by searching PubMed (n = 215), EMBASE (n = 268), and SCOPUS
(n = 459). 204 duplicates were removed. The remaining 738 articles were then screened
via their title and abstract, resulting in 55 articles for full-text screening. Reviewers
removed 39 articles that did not meet the inclusion criteria, and one article was added via
the hand search (Tarazona-Santabalbina et al., 2016). In total, 17 articles were found to
have met the inclusion criteria.
All included articles were published from 2007 to 2018 (Alghadir et al., 2016; Baker et
al., 2010a, b; Cassilhas et al., 2007; Chupel et al., 2017; Damirchi et al., 2018; Erickson
et al., 2011; Fragala et al., 2014; Kohanpour and Peeri, 2017; Leckie et al., 2014; Maass
et al., 2016; Muscari et al., 2010; Rehfeld et al., 2018; Ruiz et al., 2015; TarazonaSantabalbina et al., 2016; Tsai et al., 2015; Vaughan et al., 2014). The inter-rater
agreement was high (Title and Abstract Kappa = 0.76; Full-Text Kappa = 1.00) during the
screening process (Supplemental Material 2).
The majority of items measuring bias were rated “Unclear” for each trial, with the
exception of two articles (Ruiz et al., 2015; Vaughan et al., 2014). Random sequence
generation, allocation concealment, blinding of participants and personnel, and selective
reporting were predominantly ranked “Unclear,” as many studies did not report these
methods in detail. Studies frequently reported the blinding of outcome assessments, but
many authors did not indicate any specific blinding procedures. The item assessing the
extent to which outcome data reported in the studies was incomplete was more frequently
ranked as “High” or “Low,” as opposed to “Unclear,”. Because randomized controlled
trials were pre-registered in national databases which showed an explicit record of the
initial plan of the study and outcome data, we were able to assess risk of bias in each
study (Figure 2.2, Figure 2.3).
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Table 2.3 Characteristics of studies utilizing aerobic exercise interventions.
Sample Characteristics
Author

Country
Cohort

Alghadir et
al., 2016

Saudi
Arabia

Baker et al.,
2010a

USA

Older Adult,
Healthy
Older Adult,
Prediabetes/
T2DM

Baker et al.,
2010b

USA

Older Adult,
MCI

Erickson
et al., 2011

USA

Kohanpour
et al., 2017
Leckie et
al., 2014

Sample Size
(Female)

Intervention Details
Mean Age
in Years (SD)

Exercise Type

I: 66.8 (3.7)
C: 67.3 (2.8)

Aerobic
Training
Aerobic
Training

33 (17)

I: 66 (6.0)
C: 71 (7.5)
I: F: 65.3 (9.4)
M: 70.9 (6.7)
C: F: 74.6 (11.1)
M: 70.6 (6.1)

Older Adults,
Healthy

120 (80)

I: 67.6 (5.81)
C: 65.5 (5.44)

Aerobic
Training

Iran

Older Adults,
MCI, Males

61 (0)

67.85 (3.89)
(DNR group age)

Aerobic
Training

USA

Older Adults,
Healthy

92 (59)

I: 67.23 (5.39)
C: 66.38 (5.83)

Maass et
al., 2016

Germany

Older Adults,
Healthy

40 (22)

I: 68.8 (4.5)
C: 67.9 (4.1)

Aerobic
Training
Aerobic
Training,
Interval
Training

Muscari et
al., 2009

Italy

Older Adults,
Healthy

120 (58)

I: 68.8 (2.5)
C: 69.6 (2.8)

Aerobic
Training

Rehfeld et
al., 2018

Germany

Older Adults,
Healthy

38 (20)

I1: 68.16 (4.31)
I2: 68.72 (2.68)

Dance
Training

100 (35)

28 (18)

Aerobic
Training

Duration
24 weeks,
3x/ week,
45-60 mins
24 weeks,
4x/ week,
45-60 mins
24 weeks,
4x/ week,
45-60 mins
52 weeks,
3x/week,
40 mins
12 weeks,
3x/ week,
26 mins
52 weeks,
3x/week,
40 mins
12 weeks,
3x/ week,
30 mins
52 weeks,
3x/ week,
60 mins
24 weeks,
2x/ week,
90 mins

Blood
Marker
Measured
CRP: =
(decreased in both
I and C)

Cognitive Domain
Measured

EF: ↑, LM: ↑, CA: ↑,
Lang: ↑, P-MF: ↑

BDNF: M/F: =
IGF-1: F: =, M: ↑

EF: ↑, CA: ↑,
LM: =, Lang: =
EF: F: ↑, M: =
CA: F: ↑, M: =
Lang: F: ↑, M: =
LM: M/F: =

BDNF: =

LM: =

BDNF: ↑

GC: ↑

BDNF: =

EF: =

BDNF: =
IGF-1: =
VEGF: =

LM: =

CRP: ↓

GC: ↑

BDNF: I1: ↑

EF: =, CA: ↑,
LM: ↑, Lang: =

BDNF: =
IGF-1: =

Note: Articles are listed in alphabetical order. Studies with multiple interventions are numbered i.e. I1, I2, etc. Age (years) is mean ± standard deviation. I =
intervention; C = control; Where males and females are measured separately, M = male, F = female; BDNF = brain derived neurotrophic factor; IGF-1 = insulinlike growth factor; VEGF = vascular endothelial growth factor; CRP: c-reactive protein; IL-6: interleukin 6; CA: complex attention; EF = executive function; LM
= learning and memory; Lang = language; P-MF = perceptual-motor function; GC = general cognition; DNR = did not report; ↑ = significantly increased; ↓ =
significantly decreased; = = unchanged.
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Table 2.4 Characteristics of studies utilizing resistance training interventions.
Sample Characteristics
Author

Country
Cohort

Cassilhas
et al. 2007

Chupel et
al., 2017

Fragala et
al., 2014

Tsai et al.,
2015

Brazil

Older Adult,
Healthy, Males

Portugal

Institutionalized,
Older Adult,
MCI, Females

USA

Older Adults,
Healthy

Taiwan

Older Adults,
Healthy, Males

Intervention Details

Blood
Marker
Measured

Cognitive
Domain
Measured

Sample Size
(Female)

Mean Age
in Years (SD)

Exercise Type

Duration

62 (0)

I1: 68.04 (0.67)
I2: 69.01 (1.10)
C: 67.04 (0.54)

Resistance:
I1: (80% 1rm)
I2: (50% 1rm)

24 weeks,
3x/week,
60 mins

IGF-1: I1: ↑
I2: ↑

LM: I1: ↑
I2: ↑
CA: I1:↑
I2: ↑

33 (33)

I: 83.50 (5.13)
C: 82.12 (6.41)

Resistance

28 weeks,
2-3x/week,
mins DNR

CRP: =

GC: ↑

25 (DNR sex)

70.64 (6.11)
(DNR group
differences)

Resistance

6 weeks,
2x/week,
mins DNR

BDNF: =

P-MF: ↑

48 (0)

I: 70.79 (3.39)
C: 72.00 (4.14)

Resistance

52 weeks,
3x/ week,
60 mins

IGF-1: ↑

CA: ↑

Note: Articles are listed in alphabetical order. Studies with multiple interventions are numbered i.e. I1, I2, etc. Age (years) is mean ± standard deviation. I =
intervention; C = control; Where males and females are measured separately, M = male, F = female; BDNF = brain derived neurotrophic factor; IGF-1 = insulinlike growth factor; VEGF = vascular endothelial growth factor; CRP: c-reactive protein; IL-6: interleukin 6; CA: complex attention; EF = executive function; LM
= learning and memory; Lang = language; P-MF = perceptual-motor function; GC = general cognition; DNR = did not report; ↑ = significantly increased; ↓ =
significantly decreased; = = unchanged.
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Table 2.5 Characteristics of studies utilizing multimodal exercise interventions.
Sample Characteristics
Author

Country
Cohort

Damirchi et
al., 2018

Iran

Ruiz et
al., 2015

Spain

Older Adults, MCI,
Females
Institutionalized,
Older Adults,
Non-demented

Spain

Older Adults,
Frail

TarazonaSantabalbina
et al. 2016

Vaughan et
al., 2014

Rehfeld et
al., 2018

Australia

Older Adults,
Healthy, Females

Germany

Older Adults,
Healthy

Sample Size
(Female)

Intervention Details
Mean Age
in Years (SD)

Exercise Type

8 weeks,
3x/week,
45 mins
8 weeks,
3x/ week,
45 mins

BDNF: =

BDNF: =

GC: =

BDNF: =

GC: =

20 (20)

40 (32)

I: 92.1 (2.3)
C: 92.3 (2.3)

100 (54)

I: 79.7 (3.6)
C: 80.3 (3.7)

Aerobic, Resistance
Aerobic,
Resistance,
Stretching, and
Proprioception

I: 69.0 (3.1)
C: 68.8 (3.5)

Aerobic,
Resistance, Motor
Fitness, and
Stretching

16 weeks,
2x/ week,
60 mins

BDNF: ↑

I2: 68.72 (2.68)

Aerobic,
Resistance, and
Stretching

24 weeks,
2x/ week,
90 mins

BDNF: I2: =

38 (20)

24 weeks,
5x/ week,
65 mins

Cognitive
Domain
Measured
LM: =
CA: =
EF: =

I: 68.81 (3.68)
C: 69.11 (4.93)

48 (48)

Aerobic,
Resistance

Duration

Blood
Marker
Measured

EF: ↑
CA: ↑
Lang: ↑
EF: =
CA: ↑
LM: ↑
Lang: =

Note: Articles are listed in alphabetical order. Studies with multiple interventions are numbered i.e. I1, I2, etc. Age (years) is mean ± standard deviation. I =
intervention; C = control; Where males and females are measured separately, M = male, F = female; BDNF = brain derived neurotrophic factor; IGF-1 = insulinlike growth factor; VEGF = vascular endothelial growth factor; CRP: c-reactive protein; IL-6: interleukin 6; CA: complex attention; EF = executive function; LM
= learning and memory; Lang = language; P-MF = perceptual-motor function; GC = general cognition; DNR = did not report; ↑ = significantly increased; ↓ =
significantly decreased; = = unchanged.
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Table 2.6 Exercise Parameters.
FITT-VP
Study

Frequency

Alghadir et al.,
2016

I: 3x/week for 24weeks

Baker et al.,
2010a

I: 4x/week for 6months

Baker et al.,
2010b

I: 4x/week for 6months

Erickson et al.,
2011

I: 3x/week for 1-year

Intensity
I: 60-70% of target HR max (Karvonen
method)
I: Exercise duration and intensity were
gradually increased over the first 6 weeks
until exercising at 75% to 85% of HRR,
and then remained at that intensity
I: Exercise duration and intensity were
gradually increased over the first 6 weeks
until exercising at 75% to 85% of HRR,
and then remained at that intensity

Time
(min
/week)

Type

Volume
(min/week)

Progression

I: 45-60

I: Aerobic exercise
C: Unclear

I: 135-180

I: Not reported

I: 45-60

I: Aerobic exercise
C: Stretching and balance

I: 180-240

I: See Intensity

I: 45-60

I: Aerobic exercise
C: Stretching and balance

I: 180-240

I: See Intensity

I: 50-60 % week 1-7; 60-75% of target HR
I: 10-40
max (Karvonen method) for remainder

I: Aerobic exercise
C: Stretching and toning

I: 30-120

Kohanpour et al., I: 3x/week for 122017
weeks

I: 75%- 85% of HRR max

I: Aerobic exercise
C: Unclear

I: 24-78

Leckie et al.,
2014

I: 3x/week for 1-year

I: 50-60 % week 1-7; 60-75% of target HR
I: 10-40
max (Karvonen method) for remainder

I: Aerobic exercise
C: Stretching and toning

I: 30-120

Maass et al., 2016

I: 3x/week for 3months

I: Target HR (Karvonen et al.), starting at
65%

Muscari et al.,
2009

I: 3x/week for 12months

I: Individually programmed in an
I: 60
incremental manner, up to 70% of max HR

I: 8-26

I: 5-30

I: Aerobic exercise
C: Muscle relaxation and
stretching
I: Aerobic exercise
C: Educational material

I: 5-min increments from week
1-7 and then remained at 40minutes for remainder
I: 5-min increments from week
1-7 and then remained at 40minutes for remainder
I: 5-min increments from week
1-7 and then 40-minutes for
remainder of program

I: 15-90

I: Increasing by 5% in steps for
4 weeks

I: 180

I: See Intensity

I: 180

I1: Continuous learning of new
movement patterns and
choreographies,
I2: Performed same exercises
repeatedly

Rehfeld et al.,
2018

I1 & I2: 2x/week for 6I1 & I2: Measured HR frequency
months

I1 & I2:
90

I1: Dance
I2: "Sport" (Aerobic,
Resistance, and Flexibility
Training)

Chupel et al.,
2017

I: 2x/week for 8-weeks
+3x/week for 12-weeks I: 6-8 on the OMNI-PES
+2x/week for 8-weeks

I: 45

I: Resistance exercise
C: Did not follow any type I: 90-135
of exercise program

I: Weeks 1-14 = yellow band;
15-28 = red band
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Cassilhas et al.
2007

I1 & I2: 3x/week for
24-weeks

I1: 50 of 1-RM
I2: 80% of 1-RM

Fragala et al.,
2014

I: 2x/week for 6-weeks I: 5-6 on the OMNI-PES

I: 60
I: Not
reported

I1 & I2: Resistance
exercise
I: 180
C: Warm-up and stretching
I: Resistance exercise
I: Unclear
C: No intervention

Tsai et al. 2015

I: 3x/week for 12months

I: 75–80% 1- RM

I: 60

I: Resistance exercise
C: Did not receive a
specific intervention or
group activity

Damirchi et al.,
2018

I: 3/week for 8-weeks

I: Aerobic = 55 - 75 % of HRR
(Karvonen)
Resistance = RPE within 13 to 15 range

I: 41-55

I: Multi-domain (aerobic
and resistance exercise)
C: no intervention

I: 123-165

I: Multi-domain (aerobic,
resistance, and stretching
exercises)
C: Gentle stretching

I: 120-135

I: Multi-domain (aerobic,
strength, coordination,
balance, and flexibility
exercises)
C: No training

I: 325

Ruiz et al., 2015

TarazonaSantabalbina et
al. 2016

Vaughan et al.,
2014

I: Aerobic = 10-12 on Borg’s conventional
6–20 point scale of RPE (confirmed via
I: 3x/week for 8-weeks talk test)
I: 40-45
Resistance training = 30-70% of estimated
1-RM
I: Aerobic training = 40-65% of maximum
HR, increasing progressively to 65%
I: 5x/week for 24Strength training = 25% of 1-RM for
I: 65
weeks
months 1-2, 50% for months 3-4, and 75%
for months 5-6

I: 2x/week for 16weeks

I: Aerobic = 3-4/10 RPE
Resistance = 2 sets of 6-8 reps

I: 60

I: 180

I: Multi-domain (aerobic,
strength, and motor fitness)
I: 120
C: Maintained usual
activities

I1 & I2: 1-RM testing repeated
at week 10, 15, 18, and 21
See Intensity
I: As each individual’s muscle
strength increased, their
prescribed training load was also
raised to ensure they performed
the training at taregt 1-RM
I: Aerobic = incrementally
reached max HRR by eighth
week
Resistance = not reported
I: Aerobic = lasted from 5min at
the start of the program to 10–
15min at the end
Resistance = weekly load
increase of ~5 % of 1RM
I: Aerobic = increased
progressively
Resistance = See intensity repetitions and sets were also
manipulated
I: Aerobic = Increasing number
of simultaneous limb
movements
Resistance = Commence with
no weight, progress to light
weights (1kg)

Note. Details of exercise interventions according to FITT-VP (Frequency, Intensity, Time, Type, Volume, and Progression) parameters. Note that some exercise interventions did
not clarify an element of the parameters. Volume is calculated as sessions per week x minutes per session and therefore, a range is required for some studies, which represents the
lowest and highest number of minutes required. Volume does not account for rest periods in interventions that included resistance exercise. Additionally, we did not include
information on modalities (e.g., machine, free-weight, bands, etc.), or repetition, rest, and set schemes for resistance exercise. HR = heart rate; HRR = heart rate reserve; OMNI-PES
= OMNI perceived exertion scale; 1-RM = 1 repetition maximum; RPE = rating of perceived exertion; min = minutes

Identification
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Database Search (n=942)
PubMed = 215
EMBASE = 268
SCOPUS = 459

Eligibility

Articles excluded (n=887)
Reason:
• 676 articles: Title and
abstract irrelevant
to study
• 211 articles: Duplicate
articles
Full-text articles assessed for
eligibility
n=55

Articles added from references
(n=1)

Quality Analysis

.

Articles selected for quality
assessment
n=17

Full-text articles excluded (n=39)
Reason:
• 14 articles: not RCT
• 8 articles: exercise modality
unclear/nonexistent/acute
• 9 articles: incorrect cohort
• 7 articles: lacking/subjective
measure of cognition
• 1 article: insufficient blood
data measured/reported

Articles included in systematic
review
n= 17

Figure 2.33Flow diagram of the study selection process.
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2.2.2

Study Populations

The sample sizes of included studies ranged from 20 to 120 (n = 1008), 555 of whom
were female (55 %). Three trials recruited exclusively male participants (Cassilhas et al.,
2007; Kohanpour and Peeri, 2017; Tsai et al., 2015), while two studies exclusively
recruited females (Chupel et al., 2017; Damirchi et al., 2018). One trial did not report the
sex of their 25 participants (Fragala et al., 2014). Mean (sd) ages of the intervention
groups ranged from 66.0 (6.0) to 92.1 (2.3). Study populations were mostly drawn from
the general public (Alghadir et al., 2016; Baker et al., 2010a, b; Cassilhas et al.,
2007; Damirchi et al., 2018; Erickson et al., 2011; Fragala et al., 2014; Kohanpour and
Peeri, 2017; Leckie et al., 2014; Maass et al., 2016; Muscari et al., 2010; Rehfeld et al.,
2018; Tarazona-Santabalbina et al., 2016; Tsai et al., 2015; Vaughan et al., 2014), with
the exception of two trials of institutionalized older adults (Chupel et al., 2017; Ruiz et
al., 2015). The predominant cohorts were cognitively healthy (n = 13) (Alghadir et al.,
2016; Baker et al., 2010a; Cassilhas et al., 2007; Chupel et al., 2017; Erickson et al.,
2011; Fragala et al., 2014; Leckie et al., 2014; Maass et al., 2016; Muscari et al.,
2010; Rehfeld et al., 2018; Tarazona-Santabalbina et al., 2016; Tsai et al., 2015; Vaughan
et al., 2014); followed by MCI (n = 3) (Baker et al., 2010a; Damirchi et al.,
2018; Kohanpour and Peeri, 2017). One study labelled their criteria as “not severely
demented”, but reported mean cognitive scores in the range of MCI at baseline (Ruiz et
al., 2015).

2.2.3

Exercise Protocols

The included studies used the following modalities: aerobic training (AT) (Alghadir et
al., 2016; Baker et al., 2010a, b; Erickson et al., 2011; Kohanpour and Peeri,
2017; Leckie et al., 2014; Maass et al., 2016; Muscari et al., 2010; Rehfeld et al., 2018);
resistance training (RT) (Cassilhas et al., 2007; Chupel et al., 2017; Fragala et al.,
2014; Tsai et al., 2015); and multimodal (MMT), which includes AT and RT (Damirchi
et al., 2018; Ruiz et al., 2015), with stretching (Rehfeld et al., 2018), proprioception
training (Tarazona-Santabalbina et al., 2016) or motor fitness training (Vaughan et al.,
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2014). The trial by Rehfeld et al. (2018) employed two distinct exercise interventions
(dance and multimodal), both of which were included in this review. Two trials utilized
multi-domain interventions including the use of lavender essence (Kohanpour and Peeri,
2017) and cognitive training (Damirchi et al., 2018). However, both trials included
exercise-only groups, so the multi-domain interventions were not incorporated in the data
extraction.

2.2.4

Aerobic Training (AT)

Nine trials included AT interventions, with sample sizes ranging from 28 to 120
participants, reaching a total of 632 participants, 49 % of whom were female. All trials
recruited participants from the general public. One trial recruited exclusively male
participants (Kohanpour and Peeri, 2017). Two trials recruited participants with MCI
(Baker et al., 2010a; Kohanpour and Peeri, 2017), while the remaining seven trials
recruited cognitively intact older adults.
Interventions ranged from 12 to 52 weeks, 2–4 sessions per week, and from 26−90 min.
The AT was performed using ergometers (e.g. treadmill, stationary bike, etc.) or walking,
running, and dancing. The intensity of AT was controlled by heart rate reserve and
ratings of perceived exertion (Table 2.3).
Of the nine studies that investigated AT, seven measured growth factors (Baker et al.,
2010a, b; Erickson et al., 2011; Kohanpour and Peeri, 2017; Leckie et al., 2014; Maass et
al., 2016; Rehfeld et al., 2018) and two measured inflammatory markers (Alghadir et al.,
2016; Muscari et al., 2010). Two of the seven studies measuring BDNF found a
significant increase in BDNF concentration (Kohanpour and Peeri, 2017; Rehfeld et al.,
2018), and five studies did not find any significant changes (Baker et al.,
2010a, b; Erickson et al., 2011; Leckie et al., 2014; Maass et al., 2016). One study
measured VEGF and did not find significant changes (Maass et al., 2016). Only one of
the three studies measuring IGF-1 showed a significant increase in concentration;
however, this was only in the males (Baker et al., 2010b). Of the studies exhibiting a
positive relationship between aerobic exercise and growth factors, only one study that
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measured BDNF showed improvements in cognitive performance (Kohanpour and Peeri,
2017). However, no formal analysis examined the relationship between the changes in
BDNF concentration and cognitive outcomes. The majority of AT trials elicited
improvements in at least one cognitive domain (n = 6) (Alghadir et al., 2016; Baker et al.,
2010a, b; Kohanpour and Peeri, 2017; Muscari et al., 2010; Rehfeld et al., 2018). Overall,
there was no consistent pattern in the review of these articles that linked the duration,
frequency, or time spent on the AT to cognitive and growth factor changes.
Both of the studies measuring the effect of AT on inflammatory markers examined CRP.
Only one study showed a significant decrease in CRP concentration post-intervention
(Muscari et al., 2010). Both studies measuring CRP found cognitive improvements
(Alghadir et al., 2016; Muscari et al., 2010).

2.2.5

Resistance Training (RT)

Four trials used RT interventions, and they included a total of 168 participants (ranging
from 25−62 participants), 19 % of whom were female. Recruitment was from the general
public (Cassilhas et al., 2007; Fragala et al., 2014; Tsai et al., 2015) and an institution
(Chupel et al., 2017). Two trials recruited exclusively male participants (Cassilhas et al.,
2007; Tsai et al., 2015) and one recruited female participants (Chupel et al., 2017). Two
trials recruited participants with MCI (Chupel et al., 2017; Tsai et al., 2015) and two
recruited cognitively intact older adults (Cassilhas et al., 2007; Fragala et al., 2014).
The RT interventions ranged from 6 to 52 weeks, 2−3 times per week, and lasted 60 min
in the two studies that reported the session durations. The RT interventions utilized
resistance bands and machines. Each trial used a range of 1–3 sets per exercise and 8–15
reps per set, depending on the intervention phase. The intensity of exercises was
monitored using the 1-repetition maximum test and ratings of perceived exertion (Table
2.4).
Three out of four RT interventions measured neurotrophic factor concentrations
(Cassilhas et al., 2007; Fragala et al., 2014; Tsai et al., 2015), while one measured
inflammatory markers (Chupel et al., 2017). Of the three studies measuring neurotrophic
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factors, two measured IGF-1 (Cassilhas et al., 2007; Tsai et al., 2015), and one measured
BDNF (Fragala et al., 2014). Both of the studies measuring IGF-1 demonstrated a
significant increase in IGF-1 concentration, as well as a significant increase in cognitive
scores (Cassilhas et al., 2007; Tsai et al., 2015). The interventions that measured BDNF
(n = 1) and the inflammatory marker CRP (n = 1) did not elicit significant changes
(Chupel et al., 2017; Fragala et al., 2014) (Table 2.4).

2.2.6

Multimodal Training (MMT)

Five trials used MMT interventions (Damirchi et al., 2018; Rehfeld et al., 2018; Ruiz et
al., 2015; Tarazona-Santabalbina et al., 2016; Vaughan et al., 2014) and ranged from 20
to 100 participants (n = 226), 72 % of whom were female. Recruitment was from the
general public (Damirchi et al., 2018; Rehfeld et al., 2018; Tarazona-Santabalbina et al.,
2016; Vaughan et al., 2014) and an institution (Ruiz et al., 2015). Two trials recruited
exclusively male participants (Cassilhas et al., 2007; Tsai et al., 2015), and one trial
recruited only female participants (Chupel et al., 2017). One trial recruited participants
with MCI (Damirchi et al., 2018), as opposed to cognitively intact older adults (n = 4).
The MMT interventions ranged from 8 to 24 weeks, were performed 3–5 times per week
and lasted 45−90 min. The RT portions of the MMT interventions utilized low-impact,
multi-use devices, such as chairs, balls, resistance bands, light dumbbells, and resistance
machines. The AT portions of each study used ergometers, walking, or stairs for
10−40 min. Intensity was measured by using heart rate reserve and ratings of perceived
exertion. Three of the five studies also used other exercise modalities such as stretching
(Rehfeld et al., 2018), stretching and proprioception (Tarazona-Santabalbina et al., 2016),
or stretching and motor fitness (Vaughan et al., 2014) (Table 2.5).
Every included MMT intervention measured BDNF concentration (n = 4), but only one
demonstrated a significant increase in concentrations post-intervention (Vaughan et al.,
2014). However, two MMT interventions showed improvements to cognitive
performance in at least one domain (Rehfeld et al., 2018; Vaughan et al., 2014).
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2.2.7

Sex Differences

All of the three studies that only included males resulted in a significant increase in
neurotrophic factor concentrations and also showed significant increases in cognitive
scores (Cassilhas et al., 2007; Kohanpour and Peeri, 2017; Tsai et al., 2015). The one
study measuring sex differences in the same sample showed significant increases in
neurotrophic factor concentrations in males, however no significant improvements were
seen in the cognitive scores. Conversely, the females in this sample exhibited
significantly improved cognitive performance, but did not show changes in neurotrophic
concentrations (Baker et al., 2010b). Two of the three studies that exclusively recruited
females did not show any significant changes to blood marker concentrations (Chupel et
al., 2017; Damirchi et al., 2018). Significant improvements in cognitive performance
were elicited for two thirds of the female-only trials (Chupel et al., 2017; Vaughan et al.,
2014).

2.2.8

Cognitive Performance after Exercise

In total, 11 out of 18 interventions increased performance in at least one cognitive
domain. Specifically, complex attention improved in seven and eight of nine
interventions in males and females, respectively (Alghadir et al., 2016; Baker et al.,
2010a, b; Cassilhas et al., 2007; Rehfeld et al., 2018; Tsai et al., 2015; Vaughan et al.,
2014); executive function improved in three and four of six interventions for males and
females, respectively; learning and memory improved in four and four of nine
interventions for males and females, respectively; language improved in two and three
interventions for males and females, respectively (Alghadir et al., 2016; Baker et al.,
2010b; Vaughan et al., 2014); perceptual-motor function improved in two and two of two
interventions for males and females, respectively (Alghadir et al., 2016; Fragala et al.,
2014); and global cognition improved in three and three of five interventions for males
and females, respectively (Chupel et al., 2017; Kohanpour and Peeri, 2017; Muscari et
al., 2010; Ruiz et al., 2015; Tarazona-Santabalbina et al., 2016).
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Seven trials performed correlation analyses of changes in blood marker concentrations
and cognitive performance (Alghadir et al., 2016; Damirchi et al., 2018; Erickson et al.,
2011; Fragala et al., 2014; Maass et al., 2016; Ruiz et al., 2015; Tsai et al., 2015). CRP
had a strong negative correlation with every cognitive domain in one trial (Alghadir et al.,
2016). BDNF did not have a significant correlation with cognitive performance
(Damirchi et al., 2018; Erickson et al., 2011; Fragala et al., 2014; Ruiz et al., 2015). IGF1 was had a moderate positive correlation with learning and memory (Maass et al., 2016)
and complex attention (Tsai et al., 2015) performance. One trial found that BDNF was a
mediator of the exercise-executive function relationship as a function of age (Leckie et
al., 2014).

2.2.9

Meta-Analyses Results

Studies examining changes following aerobic training in CRP, IL-6, and VEGF did not
meet the minimum criteria of at least three independent studies. However, eight
independent studies examined BNDF concentrations in individuals assigned to control or
active experimental conditions, and were therefore included in the meta-analysis
(Damirchi et al., 2018; Erickson, 2010; Fragala et al., 2014; Kohanpour and Peeri,
2017; Leckie et al., 2014; Maass et al., 2016; Tarazona-Santabalbina et al.,
2016; Vaughan et al., 2014).

2.2.10 Weighted Results
As evidenced in Figure 2.4, of the eight studies, only one (Kohanpour and Peeri, 2017)
yields results that favour the hypothesis that the experimental group has higher BDNF
concentrations post intervention (relative to the control group). This is evidenced by the
fact that the 95 % confidence interval wings extend entirely within the right hand side
of Fig. 4. It is critical to note that while the results of this study are uniquely
heterogeneous relative to the other seven studies—the sample size of Kohanpour and
Peeri (2017) is very small (N = 10 in each group)—thus it had a low overall weight in the
model. Conversely, the studies with the highest sample sizes (Erickson, 2010; Tarazona-
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Santabalbina et al., 2016)—and therefore overall weights—demonstrate no particular
trend in either direction.
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Figure 2.44Forest Plot of Meta-Analysis. BDNF = Brain Derived Neurotropic Factor; IV = Intervention.
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2.2.11 Overall Effect
Across the eight studies, there is a moderate degree of heterogeneity (I2 = 44 %), thus the
findings should be interpreted with caution. The overall results are slightly in favour of
the hypothesis that aerobic exercise yields higher BDNF concentrations, as compared to
control exercises. But importantly, as depicted in Fig. 4, there is some overlap across the
center line of no effect. This indicates that the overall effect is not completely indicative
of increased BDNF post intervention and this is confirmed statistically, as the test of the
overall effect is not significant, Z = 1.12, p = .26.

2.3

Discussion

This systematic review and meta-analysis investigated the effects of physical exercise on
inflammatory and neurotrophic biomarker concentrations in clinical trials that aimed to
improve cognition as a primary outcome. We found that exercise interventions,
independent of the modality, were associated with changes in neurotropic and
inflammatory blood marker concentrations in 8 of the 18 trials. IGF-1 was the most
responsive to exercise, independent of modality. Aerobic training primarily increased or
did not change BDNF concentration while resistance training increased IGF-1
concentration. MMT interventions elicited changes to BDNF in one of four trials. Males
demonstrated greater blood marker changes in response to exercise. Finally, 11 of 17
trials resulted in an improvement in at least one domain of cognition and 5 (46 %) of
those trials also demonstrated positive changes in biomarker concentrations. IGF-1
showed moderate positive correlations with LM and CA, while CRP was negatively
correlated with all cognitive domains in one trial. There were no significant correlations
between BDNF and cognitive outcomes.
Since the time of running this search (January 2019), two large scale studies have been
published (as of December 2020) that show similar trends. Specifically, a study in which
146 participants were randomized to receive either aerobic training, cognitive training,
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mindfulness training, or an active control found that the aerobic training group did not
show significant changes in BDNF following the intervention (Ledreux et al., 2019).
Similarly, another recently published study with 112 nursing home residents in Spain
discerned that multimodal training did not significantly change BDNF concentrations in
the intervention condition (Arrieta et al., 2020). These findings are consistent with the
findings of our systematic review indicating that BDNF concentrations either
increase or remain unchanged following aerobic or MMT interventions.
Lastly, although our systematic review excluded RCTs in which the intervention
consisted of only one acute, single bout intervention session, a recent study found a
significant increase in BDNF concentrations following an acute bout of high-intensity
exercise (Devenney et al., 2019). This, too, is consistent with our findings that AT either
increases or does not change BDNF concentrations.

2.3.1

Effects of Exercise Modalities on Blood Markers and
Cognition

AT was the most commonly studied intervention strategy (n = 9), followed by MMT
(n = 5), and RT (n = 4). The AT interventions were associated with positive changes in
BDNF and improved cognitive performance in six of the nine trials. Two RT
interventions increased IGF-1 concentrations, but all four RT interventions improved
cognitive performance. Interestingly, only one of five MMT intervention led to
significant increases in BDNF concentration and two trials improved cognitive
performance.
Consistent with the results of this review, previous research has suggested that AT
increases BDNF concentrations, while RT primarily functions to increase IGF-1
concentrations (Cassilhas et al., 2012). As all MMT programs in this review utilize both
RT and AT, we can expect that a more interactive cascade can be driving the observed
cognitive improvements. Thus, more comprehensive measurements of neurotrophic and
inflammatory markers are necessary to delineate the potentially divergent mechanisms
that mediate MMT-induced cognitive improvements.

60
Recent systematic reviews and meta-analyses measuring the effect of exercise on
biomarkers in older adults with MCI or dementia reported that exercise significantly
increased BDNF concentrations and significantly decreased IL-6 and tumor necrosis
factor-α (TNF-α) concentrations (Stigger et al., 2019). These results may relate to the
relatively low baseline concentration of neurotrophic factors (Xie et al., 2019) or high
concentrations of inflammatory cytokines in individuals with MCI or dementia (Öztürk et
al., 2007), compared to healthy older adults. This may indicate that participants who have
cognitive impairments have more room to ameliorate concentrations of neurotrophic and
inflammatory markers after longitudinal exercise, while cognitively intact participants
may be limited by a ceiling effect. However, data from the studies that recruited
participants with MCI (n = 4) did not suggest that exercise was more effective at
increasing or decreasing growth factor and inflammatory cytokine concentrations,
respectively, for participants with cognitive impairments (Baker et al., 2010b; Fragala et
al., 2014; Tsai et al., 2015). Previous reviews of exercise effects on neurotrophic and
inflammatory concentrations were limited by the number of trials and heterogeneity,
especially when considering the complexity and interactive nature of the variables
(Stigger et al., 2019). Notably, the Stigger et al. (2019) review did not include studies
with healthy control participants—but ours did. Additionally, like the Stigger et al.
(2019) review, we also conducted a meta-analysis on the data extracted.
Overall, the results of the meta-analysis suggest a minimal trend towards increases in one
growth marker (BDNF) following aerobic exercise. This finding, however, is not
statistically significant. Heterogeneity across studies paired with small sample sizes and
the lack of studies meeting our inclusion criteria that examine biological markers aside
from BDNF strongly suggest that this field is wanting of more robust research.
One hypothesis explaining the heterogeneity in biomarker concentrations post
intervention across studies may be the variability in exercise parameters (see Table 2.6).
Generally, there was considerable variability across all exercise parameters (frequency,
intensity, time, type, volume, and progression). For example, total volume of exposure
across studies ranged from 15−325 min per week; thus, in some studies, volume of
exercise intervention exposure was less than the recommended 150 min per week of
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aerobic activity for older adults (https://csepguidelines.ca/adults-65/) to 240 min per
week. The variability observed across studies in exercise training exposure does not
appear to explain the differences across studies in blood marker concentrations post
intervention. For example, the Kohanpour and Peeri (2017) study showed a robust
increase in BDNF concentrations following intervention; however, exposure to the
exercise intervention occurred over only 12 weeks. In contrast, Erickson et al.
(2011) and Leckie et al. (2014) conducted their exercise intervention sessions over an
entire year. But despite this prolonged exposure, increases in BDNF concentrations post
intervention were smaller relative to those observed in other studies (i.e., Kohanpour and
Peeri, 2017). Taken together, what these data indicate is that differences across studies in
intervention exposure (exercise frequency) do not appear to shed light on the variability
observed across studies in biomarker changes post intervention.

2.3.2

Discussion of Sex Differences

There were notable sex differences in changes to biomarker concentrations in trials that
exclusively recruited one sex, as well as the single trial that analyzed sex-differences in
their sample. In particular, every male-only cohort (n = 3) exhibited increases in
neurotrophic factor or decreases in inflammatory markers that accompanied significant
improvements in cognition (Cassilhas et al., 2007; Kohanpour and Peeri, 2017; Tsai et
al., 2015), but there was no correlation between changes in blood marker and cognitive
function when analyzed (Tsai et al., 2015). Also, the single trial that measured sex
differences within their sample found significant improvements to neurotrophic factor
concentrations in the male, but not the female participants (Baker et al., 2010b).
Interestingly, none of the female-only cohorts (n = 3) showed changes to blood marker
concentrations (Chupel et al., 2017; Damirchi et al., 2018; Vaughan et al., 2014).
The sex-specific biomarker responses might be related to the different exercise modalities
performed. In particular, two of three female-only cohorts participated in MMT; the only
modality that did not elicit any changes to blood marker concentrations. Also, no female
samples exclusively participated in AT. Alternatively, two of three male-only cohorts
participated in RT, which was the modality exhibiting the greatest proportion of positive
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changes to blood marker concentrations and cognitive scores. Interestingly, trials utilizing
RT were mostly composed of male participants, suggesting that sex might moderate the
positive neurotrophic outcomes of RT. Thus, the sex differences might be confounded by
the lack of equal representation of sexes across exercise modalities, or potential sexrelated moderation. Alternatively, there are sex-specific differences within the aging
process (Barha and Liu-Ambrose, 2018; Gordon et al., 2017), which may be related to the
sex-specific responses to intervention strategies. This has been addressed by recent
studies investigating how pre-frail older females respond to free-weight resistance
training interventions to reduce frailty and improve functional capabilities with promising
results (Bray et al., 2019a, 2019b). Therefore, increased attention to the sex-specific
responses to exercise is imperative to improve understanding of this complex
relationship.
There is a growing body of literature examining sex-specific responses to exercise
interventions implemented in older adults at risk for dementia (Barha and Liu-Ambrose,
2018). For example, results from a recent systematic review and meta-analysis indicate
that exercise intervention studies in which samples are predominantly female show more
robust benefits on executive function than those with fewer female participants (Barha et
al., 2017). These data suggest that the cognitive domains involved in executive
functioning in women may be more sensitive to the neurological cascade resultant of
exercise interventions. Additionally, there is evidence suggesting that there may be an
interaction between the type of exercise intervention and sex on cognitive outcomes.
Aerobic exercise, for example, appears to be more effective in producing cognitive
benefits to women than to men (Colcombe and Kramer, 2003). Taken together, the
literature suggests that sex is a critical factor to consider in studies examining neutrally
mediated cognitive outcomes of exercise interventions in aging populations.

2.3.3

Cognitive Performance Outcomes

In total, 11 out of 18 interventions augmented at least one domain of cognition. More
specifically, exercise preferentially improved complex attention in seven and eight out of
nine interventions in males and females, respectively, and improved perceptual-motor
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function in two of two interventions. These findings strengthen the relationship between
exercise and cognition, especially in perceptual-motor function, which was the least
measured cognitive domain in this review. Other domains showed only moderate
modulation by exercise. Out of the exercise modalities, RT interventions were the most
effective in augmenting cognitive performance. Further, RT elicited cognitive benefits in
complex attention, learning and memory, perceptual-motor function, and global
cognition. Recent research investigating the effect of RT on cognition in older adults also
demonstrates this relationship. In particular, a systematic review by Li et al. (2018)
examined the cognitive effects of RT on older adults. Similar to our review, their results
indicated that longitudinal RT interventions significantly improved executive function
and global cognition performance.
From the seven trials that analyzed correlations between the changes in blood marker
concentrations and cognitive outcomes, IGF-1 seems to have the strongest correlation
with cognitive performance, showing moderate positive correlations to complex attention
(Tsai et al., 2015) and learning and memory (Maass et al., 2016). The relationship
between IGF-1 and cognition is inconsistent. For example, some work has shown that
IGF-1 is positively correlated with cognition (Okereke et al., 2006) but others suggested
that it is negatively correlated with cognition (Stein et al., 2018). Further, it has been
suggested that moderate, as opposed to a high or low, concentrations of systemic IGF-1 is
correlated with positive cognitive outcomes (Tumati et al., 2016). Thus, further research
is needed to evaluate the correlation between IGF-1 and cognitive outcomes after
exercise.
Surprisingly, in the four trials that performed correlation analyses, no correlations were
found between the changes in BDNF and cognitive outcomes. However, consistent with
previous literature (Vaynman et al., 2004), BDNF was shown to be a mediator of the
exercise-cognition relationship in one trial (Leckie et al., 2014). To establish more a
concrete understanding of how growth factors correlate with cognition, more
comprehensive neuropsychological assessments, growth factor measurements, and
appropriate statistical analyses should be utilized.
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2.3.4

Future Studies

This systematic review exposed gaps in the literature. Future research should focus on the
effect of exercise on multiple neurotrophic and inflammatory markers simultaneously,
while measuring cognitive performance. An ongoing RCT is examining the effect of
MMT on BDNF, IGF-1, VEGF, IL-6, CRP and cognitive performance in older adults
consisting of 200 participants with MCI and may help to decipher the role of these
neurotrophic and inflammatory markers (Montero-Odasso et al., 2018). Further, research
should be developed to specific exercise modalities. In addition, the role of sex-related
factors, such as hormone concentrations and their interactions with neurotrophic and
inflammatory blood markers, is a potential avenue for further research in this topic.
Additional reasons for the contrasting findings may be related to the diversity of
participants in each study. That is, future studies examining varying ethnic backgrounds
or comorbidities in the populations under study may offer fruitful insights in explaining
the mixed findings. However, in the present study, the majority of selected studies were
similar with respect to demographic characteristics such as ethnic background and
comorbidities. Finally, difference across studies can also be related to the target
population and when the intervention was provided across the spectrum of the decline.
Future research focusing on the timing in which interventions are implemented in
individuals at risk for developing dementia may provide interesting findings.

2.3.5

Limitations

Our review has limitations. Firstly, it is possible that our search strategy missed relevant
material in our selected databases. Additionally, the included studies were heterogeneous
in terms of exercise modalities and parameters, preferred blood markers, sample sizes,
cognitive domains measured, and analyses employed. Also, given the limitations of the
published studies, we reported results as “increase” or “decrease,” which limited the
examination of the relative effect size of each intervention. Further, only extracting
results of significance from the trials means that large samples sizes are required, but not
obtained, in all individual studies to prevent Type II errors. Also, the number of studies in
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our review was limited by a lack of available literature that measured both the changes to
concentrations of blood markers of interest and cognitive performance.
Regarding our meta-analyses, the eight included studies were limited by small sample
sizes, with sample sizes ranging from N = 10 per condition to N = 60 per condition, with
an average sample size of 29 individuals per arm across studies. In addition, studies were
highly heterogeneous, requiring a high degree of caution in interpreting the results. The
absence of trials that included the mean change values for inflammatory blood markers
limited our ability to perform any additional meta-analyses. And finally, trials
preferentially measured single blood markers (typically BDNF or IGF-1) in the majority
of cognitive trials and lacked measurements of inflammatory markers.

2.4

Conclusion

Exercise has an effect on the serum concentrations of neurotrophic and inflammatory
marker in cognitive trials. Specifically, AT primarily increased or did not change the
concentrations of BDNF, while RT increased or did not change the concentrations of
IGF-1. A small number of trials demonstrated changes in biomarkers may be sex specific,
as males exhibited greater increases in neurotrophic biomarker concentrations after
exercise interventions than females. This systematic review was limited by heterogeneity
of exercise modalities and parameters, as well as the variability in the measurements of
blood markers and cognition. Despite the limitations, this is the first review to examine
and compare the effect of the type of exercise on neurotrophic and inflammatory markers
on cognition in older adults. Based on the gaps detected, we suggest that further research
on the effect of exercise on cognition should simultaneously measures neurotrophic and
inflammatory markers, to gain a more comprehensive understanding of this relationship.
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